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Abstract
Background: CD14 has been postulated to play a role in chlamydial immunity and
immunopathology. There is evidence to support this role in human infections but its function in a
mouse model has not been investigated.
Methods: Female CD14 gene knockout and C57BL/6J wild type mice were infected intravaginally
with Chlamydia muridarum. The infection course was monitored by detection of viable chlamydiae
from serially collected cervical-vaginal swabs. The sequela of tubal factor infertility was assessed
using hydrosalpinx formation as a surrogate marker.
Results: A significantly abbreviated infection course was observed in the CD14 gene knockout
mice but hydrosalpinx formation occurred at similar rates between the two groups.
Conclusion: Involvement of CD14 during chlamydial infection impedes infection resolution but
this does not affect the sequela of infertility as assessed by hydrosalpinx formation.
Background
A mouse model of urogenital chlamydial infection has
been established for the study of immunity [1,2] and
pathogenesis [3-7] to chlamydial infections. While in-
roads have been made into understanding protective
immunity in this model, much less is known about the
factors associated with pathogenesis leading to the
chronic sequelae of infection. One of the sequelae is tubal
scarring and infertility, and a surrogate marker of infertil-
ity – hydrosalpinx formation [7,8]. Several recent reports
suggest that acute inflammatory responses may cause an
initial insult leading to these outcomes [7,9] but persist-
ent infections that drive chronic inflammation are also
possible causes [6].
Toll-like receptors (TLR) are a primary means of initiating
innate immune system responses through the recognition
of pathogen-associated molecular patterns (PAMPs)
[10,11]. We read with interest the recent work of Darville,
et al., that assessed the role of TLR-2 and TLR-4 in the
mouse model chlamydial infection [4]. In this study, they
found that although TLR-2 knockout (-/-) mice had a sim-
ilar infection course as wild type (wt) controls, they
showed a significant reduction in oviduct pathology and
the accompanying proinflammatory cytokine production.
A similar effect was not observed in TLR-4 mice. These
results indicated that TLR2 is a major means of signaling
to induce innate immune responses in this model.
Published: 22 September 2006
BMC Infectious Diseases 2006, 6:144 doi:10.1186/1471-2334-6-144
Received: 29 May 2006
Accepted: 22 September 2006
This article is available from: http://www.biomedcentral.com/1471-2334/6/144
© 2006 Imtiaz et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 6
(page number not for citation purposes)
BMC Infectious Diseases 2006, 6:144 http://www.biomedcentral.com/1471-2334/6/144At the time of the Darville report, our laboratory was
involved in assessing the role of CD14 in the murine
model. CD14 has been proved to be an accessory protein
for TLR4 recognition of lipopolysaccharide (LPS) and sub-
sequent transduction of intracellular signaling via nuclear
factor-kappaB [12]. While the LPS of chlamydia has been
shown to have relatively weak endotoxic activity [13], we
thought it was possible that CD14 could also function as
a critical accessory protein for other PAMPs such as heat
shock proteins (HSP) [14] or for the removal of apoptotic
cells by macrophages – an event which could regulate
inflammatory responses [5,15-17]. In humans, reports
have shown that a functional polymorphism in the CD14
gene is not involved in susceptibility to C. trachomatis
infection or fallopian tube pathology [18]. Nonetheless,
similar functional polymorphisms have been variously
associated with susceptibility to C. pneumoniae infection
and possibly pathological immune responses [19-22].
Based on these observations, we hypothesized that CD14
would be involved in chlamydial pathogenesis in the




We acquired CD14-/- breeder pairs on a C57BL/6J back-
ground (Jackson Laboratories, Bar Harbor, Maine) and
initiated a colony at the Midwestern University Animal
Resource Facility. CD14 gene deletion was confirmed by
extracting genomic DNA from tail snips or ear punches of
breeders and randomly selected offspring and assessing
the presence or absence of the neomycin resistance insert
and the CD14 gene by previously described methods
[23,24]. All mice were housed and maintained in accord-
ance with institutional and federal guidelines and each
protocol involved in the experiments detailed below was
approved by the Midwestern University Research and Ani-
mal Care Committee.
Infection and infection assessment
At 6–10 weeks of age, female CD14-/- mice and C57BL/6J
wild type (wt) controls (Harlan Sprague Dawley, Indiana-
polis, Indiana) were pretreated with progesterone (2.5 mg
subcutaneously) and infected one week later with 100
ID50 of MoPn (104 IFU Weiss strain) according to previ-
ously described methods [25]. At 4, 7, 10, and 14 days
post-infection and every 7 days thereafter, we collected
cervical-vaginal swabs for culture of MoPn in HeLa 229
monolayer and inclusion-forming units (IFU) were visu-
alized using indirect fluorescent microscopy and quanti-
tated at each time point [26]. The experiments were
repeated once with a total of 18 animals assessed in each
group for both experiments.
Assessment of gross pathology
Mice were euthanized and necropsied on day 56 post-
infection according to previously described methods [26].
This is a time frame chosen to represent 2 to 3 weeks
beyond the last culture-positive in all groups. Hydros-
alpinx, an enlarged distended oviduct filled with a clear
serous fluid, is a chronic sequela of infection that is a sur-
rogate marker of infertility and indicates fibrotic tubal
occlusion [7]. It is readily observed by the unaided eye in
most incidences but all mice were additionally observed
at 10 × magnification to ensure accuracy of results and
that minor hydrosalpinx was not missed. Each mouse was
graded as 0 (no hydrosalpinx), 1 (unilateral hydros-
alpinx), or 2 (bilateral hydrosalpinx) and the results
recorded for 2 experiments. The total number of mice
assessed for hydrosalpinx for both experiments was 21 for
C57BL/6J mice and 22 for CD14-/- mice.
Statistics
A Kruskal-Wallis analysis of the variance (variables were
animal, day post-infection and group) was used to assess
differences in infection course between the CD14-/- mice
and C57BL/6 wt mice. McNemar's chi square analysis
with Yates correction was used to determine differences in
culture-positive to culture-negative and in gross pathology
between CD14-/- mice and the C57BL/6 controls.
Results
CD14-/- mice resolve chlamydial urogenital infection more 
quickly than wild type mice
Figure 1 shows the consolidated results of IFU counts over
time for two experiments on a Log10 scale. The lines for wt
C57BL/6J and the CD14-/- mice overlapped on day 4 and
7 post-infection. However, by day 10 and 14, there was a
trend toward lower IFU recovery in the CD14-/- group. On
day 10, the mean IFU count for CD14-/- mice was approx-
imately 85% lower than that of C57BL/6J (1.7 × 105 +/-
3.1 × 105 IFU in C57BL/6J mice versus 2.9 × 104 +/- 2.8 ×
104 IFU in the CD14-/- mice). At 14 days post-infection, a
94% lower IFU count was recorded for CD14-/- mice (6.3
× 103 +/- 8.9 × 103 IFU) when compared to C57BL/6J mice
(1.1 × 105 +/- 1.6 × 105 IFU). By 21 days post-infection the
mean IFU of 11 remaining culture-positive mice out 18 in
the CD14-/- group (2.6 × 103 +/- 7.9 × 103) and 16
remaining culture-positive mice out of 18 in the C57BL/6J
wt group (7.3 × 103 +/- 1.1 × 104) was only 65% different.
Overall, the infection course as assessed by IFU count in
CD14-/- mice was significantly abbreviated when assessed
by a Kruskal-Wallis analysis of the variance (P < 0.00001).
Also, when we assessed the number of animals culture
positive of the total assessed at each time point (see table
at the bottom of Figure 1), we found that significantly
more animals had resolved infection by day 21 in the
CD14-/- group (7 of 18 resolved) than in the wt C57BL/6Page 2 of 6
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Course of C. muridarum (MoPn) infection in CD14-/- and wt C57BL/6J mice as assessed by quantitation of viable organisms shed from the ogenital tractFig r 1
Course of C. muridarum (MoPn) infection in CD14-/- and wt C57BL/6J mice as assessed by quantitation of viable organisms 
shed from the urogenital tract. Mouse pneumonitis IFUs were isolated from cervical-vaginal swabs collected at 4, 7, 10 and 14 
days and every 7 days thereafter through day 49. Each data point represents the mean (symbol) and standard deviation (vertical 
line) of IFU observed in HeLa 229 cultures of cervical-vaginal swab material collected from only the culture-positive mice as 
labeled by group in the chart at that time point based on a Log10 scale. Also, the ratio of culture-positive results out of the total 
number of mice assessed at each time point is expressed in the table below the chart. A significantly lower IFU count was 
observed in the CD14-/- group when the course of infection overall was compared by a Kruskal-Wallis analysis of the variance 
(P < 0.00001). In the table below the chart, by 21 days post-infection more mice resolved infection (culture-negative) beginning 
day 21 post-infection in the CD14-/- group (P = 0.04, McNemar's chi square analysis with Yates' correction).
BMC Infectious Diseases 2006, 6:144 http://www.biomedcentral.com/1471-2334/6/144(only 2 of 18 resolved) controls (P = 0.04, McNemar's chi
square analysis with Yates correction). A similar trend
toward fewer culture-positive mice in CD14 was observed
at 28 through 42 days post-infection but this did not
prove significant.
CD14-/- mice display similar rates of hydrosalpinx 
formation as wild type mice
Figure 2 depicts the rates of hydrosalpinx formation at 56
days post-infection in wt C57BL/6J and CD14-/- mice. We
found a similar rate of hydrosalpinx between the two
groups with CD14-/- mice displaying a 54.5% rate of hyd-
rosalpinx formation (24 of 44 oviducts assessed) and a
52.4% (22 of 42) rate in the wt C57BL/6J group (P =
0.8774, McNemar's chi square analysis with Yates correc-
tion). When considered with Figure 1, we conclude that
though the infection course is somewhat abbreviated as a
result of CD14 deletion, this has no effect on chronic
sequelae, and by extension, the degree of damage inflicted
on the tissue by the innate immune response.
Discussion
Along with LPS-binding protein (LBP) and MD-2, CD14
has been proved to be an accessory protein for TLR4 rec-
ognition of lipopolysaccharide (LPS) and subsequent
transduction of intracellular signaling via nuclear factor-
kappaB for proinflammatory cytokine production [12].
While the LPS of chlamydia has been shown to have rela-
tively weak endotoxic activity [13], we thought it possible
that a high concentration of chlamydial LPS at the foci of
an infection, could serve to synergize with other PAMPs to
initiate or influence inflammatory responses. Other possi-
ble chlamydial PAMP that could engage CD14 exist. For
example, it has been shown that CD14 binds heat shock
proteins (hsp) [14] and the chlamydial hsp has been
implicated as a hypersensitizing antigen at least partly
responsible for the pathogenesis of C. trachomatis infec-
tions [27,28]. Also, regulation of apoptosis in the murine
model has been proved to have profound effects on
immunopathology [5,15] and CD14 has been shown to
serve as receptor on macrophages for the recognition of
cells undergoing apoptosis [16,17]. In other models of
Gram-negative bacterial infection, CD14 gene knockout
mice had been proved to have altered outcomes of infec-
tion. Examples of these include Acinetobacter bauminii
[29], Legionella pnuemophila [30], Borrelia burdorferi [31]
and Salmonella typhimurium [32].
Several recent reports indicate that the Chlamydiae can
engage TLR through LPS and non-LPS-dependent path-
ways [13,20,28]. However, TLR2, and not TLR4 appears to
be important for the initial signaling pathway for proin-
flammatory cytokine production during chlamydial infec-
tion [20,33]. Most relevant to the present findings,
Darville, et al., have recently shown a lack of involvement
of the TLR4 but a prominent role for TLR2 in the MoPn
model of female urogenital chlamydial infection and in
murine fibroblasts and macrophages [4]. TLR2-/- mice
and primary cell cultures produced lower levels of proin-
flammatory chemokines and cytokines, displayed signifi-
cantly lower pathology scores and a lower rate of
hydrosalpinx formation when compared to wt control
mice. TLR4-/- mice showed no significant change in infec-
tion course or pathology but some increases in cytokine
production were observed compared to wt control mice
and primary cell lines derived from these [34].
Our present results showing a lack of involvement of
CD14 in pathogenesis largely agree with the work of the
Darville report regarding TLR4. We make this correlation
with Darville's findings because CD-14 is an integral com-
ponent TLR4 signaling pathway. In this regard, it func-
tions as a co-receptor for LPS [12], HSP [14], and
apoptotic cells for phagocytic clearance by macrophages
[17]. Some divergence with the findings of Darville, et al.
was found in the observation that there was a statistically
significant abbreviation of infection course in CD14-/-
mice, particularly during the time frame of onset of the
adaptive immune response and infection resolution (days
10–21 post-infection) [35]. Though the reason for this
observation remains unclear, it could be that signaling
through CD14-TLR4 pathway induces a proinflammatory
cytokine profile that protracts resolution of the infection
by impeding the appropriate adaptive immune response.
A complete and exhaustive study of cellular or antibody-
Rate of hydrosalpinx formation at day 56 post-infection in CD14-/- and wt C57BL/6J miceFigure 2
Rate of hydrosalpinx formation at day 56 post-infection in 
CD14-/- and wt C57BL/6J mice. The results for 44 oviducts 
assessed (22 mice) from CD14-/- mice are shown in the 
white bar whereas the results of 42 oviducts (21 mice) from 
wt C57BL/6 Jmice are shown in the black bar. The results are 
the composite of 2 separate experiments. There is no signifi-
cant difference between the two groups (P = 0.8774, McNe-
mar's chi square analysis with Yates correction).Page 4 of 6
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stantiate this hypothesis.
It should also be noted that the MoPn agent is a natural
pathogen for the mouse and sustains a significantly more
vigorous infection, a far higher incidence of ascending
upper genital tract infection, and higher acute inflamma-
tory responses than human C. trachomatis serovars in the
mouse [3]. Perhaps, a strain difference in chlamydial
PAMP expression or in host expression of TLRs could
account for this. In this respect, the application of our
results to human infections, as with all animal models,
should be carefully interpreted.
Another caveat for interpreting our results relates to our
use of progesterone pretreatment. This is used to enhance
infection by halting the rapid estrus cycle of the mouse
and providing a lush epithelial environment for growth of
this pathogen that prefers epithelial cells for replication.
Without such treatment, we have found that a one hun-
dred percent infection rate cannot be obtained unless
mice are inoculated on 2 or more consecutive days with
much higher doses of the organism. While we can find no
reports in the literature related to progesterone modulat-
ing CD14 expression, we cannot completely rule out that
pretreatment with progesterone could have blurred our
results.
Due to the required intracellular replication of the
Chlamydiae, it is more likely that intracellular pattern rec-
ognition receptors are involved in initiating host
responses. To this end, the aforementioned work by Dar-
ville, et al. [4] and more recent findings of Welter-Stahl, et
al., suggest that this may be the case [36]. These findings
indicate that intracellular pattern recognition receptors
such as Nod1 and TLR2, rather than those found extracel-
lularly, are likely candidates. While PAMP such as a rudi-
mentary peptidoglycan expressed by the Chlamydiae may
contribute to the initiation of the host response, certainly
other chlamydial ligands are involved. These findings
complicate vaccine development that targets neutraliza-
tion of chlamydial PAMPs in order to prevent harmful
inflammatory responses because restriction of expression
of TLR agonists to the intracellular niche protects these
antigens from neutralizing antibodies.
Conclusion
The results herein imply that engagement of CD14 in this
model does not affect chronic disease progression (e.g.
hydrosalpinx formation and by extension, infertility) but
does impede resolution of the infection.
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